Navigation Links
VascoScrew CC 8/60 M

ProductsVascoScrew CC 8/60 M
Company Vascomed
Item VascoScrew CC 8/60 M
Features The VascoScrew 8/60 S can be placed quickly and safely in the ventricle, appendage or the lateral wall of the atrium with low thresholds and high sensing amplitudes. High flexibility and security is provided with a quadrifilar coil and the choice of high-grade materials.
Description VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm.
Info Vascomed
Customer Service: +49-180 5-82726633
Web site: http://www.vascomed.de/

Related medicine products :

1. VascoScrew E 5/60 PU S
2. VascoScrew E 5/60 PU M
3. VascoScrew CC 5/60 PU M
4. VascoScrew CC 5/60 PU S
5. VascoScrew E 6/60 S
6. VascoScrew CC 6/60 M
7. VascoScrew E 6/60 M
8. VascoScrew P 6/60 M
9. VascoScrew E 8/60 S
10. VascoScrew CC 6/60 S
11. VascoScrew E 8/60 M
Breaking Medicine Technology:Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 2Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 3Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 4Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 5Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 6Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 7Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 8Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 9Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 10Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 11Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 12Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 13Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 14Heska Announces Extension of Credit Agreement With Wells Fargo 2Heska Announces Extension of Credit Agreement With Wells Fargo 3New Survey Reveals Health Related Fitness as Primary Focus of Middle and High School Physical Education Programs 54197 1New Survey Reveals Health Related Fitness as Primary Focus of Middle and High School Physical Education Programs 54197 2New Survey Reveals Health Related Fitness as Primary Focus of Middle and High School Physical Education Programs 54197 3New Survey Reveals Health Related Fitness as Primary Focus of Middle and High School Physical Education Programs 54197 4Texcel Medical Expands Medical Device Development 26 Manufacturing Capabilities With New Personnel Nearly 241 Million in Capital Investments 13501 1Texcel Medical Expands Medical Device Development 26 Manufacturing Capabilities With New Personnel Nearly 241 Million in Capital Investments 13501 2Texcel Medical Expands Medical Device Development 26 Manufacturing Capabilities With New Personnel Nearly 241 Million in Capital Investments 13501 3Prime Therapeutics 2009 Drug Trend Insights Shows Drug Spending Slows to Lowest Rate on Record 54189 1Prime Therapeutics 2009 Drug Trend Insights Shows Drug Spending Slows to Lowest Rate on Record 54189 2Prime Therapeutics 2009 Drug Trend Insights Shows Drug Spending Slows to Lowest Rate on Record 54189 3